Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor for the Treatment of Chronic Idiopathic Constipation (CIC)
NCT07382167Phase 3Recruiting
- Sponsor
- Ardelyx
- Start
- Jan 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenapanor in chronic idiopathic constipation (CIC), sponsored by Ardelyx. Started Jan 2026; status: recruiting.
02
Drugs
tenapanor
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT07382167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07382167.